About this trial
The two types of total coronary revascularization via left anterior thoracotomy (TCRAT) might have their potential benefits and disadvantages. The proposed randomized clinical trial here will compare 'RA-TCRAT' with 'Nonrobotic TCRAT' procedures concerning effects on hospital stays, overall healthcare costs, safety, and feasibility. If the two TCRAT procedures are comparably effective and safe, the 'Nonrobotic TCRAT' procedure is probably preferred as it seems easier to use. However, if the 'Nonrobotic TCRAT' procedure is less effective and less safe than the "robotic TCRAT,' that procedure should be preferred.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Scheduled for any type of elective minimally invasive coronary revascularization surgery.
Using CPB.
General anesthesia is provided in an endotracheally intubated patient
Disqualifiers
Planned for coronary revascularization surgery without CPB;
Planned for a combined coronary revascularization surgery and a valve or intra-cardiac surgery;
LVEF less than 35%;
Preoperative cardiogenic shock;
Trial design
Parallel
Treatments tested in this trial
Nonrobotic TCRAT
Procedure/SurgeryNonrobotic TCRAT for CABG
Robotic TCRAT
Procedure/SurgeryRobotic TCRAT for CABG
Treatment groups
Trial outcomes
Primary outcomes
The length of hospital stay
The primary outcome is the length of hospital stay, defined as the time from surgery until discharge or in-hospital death.
Secondary outcomes
Overall costs and charges
The overall healthcare costs and healthcare charges
The operating room stay
The operating room stays from entrance to transferring the patient to the ICU.
The postoperative ICU stay
The postoperative ICU stay from surgery date and time.
The need for re-explorative surgery during the same admission.
The need for re-explorative surgery during the same admission.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Mohamed R El Tahan
Lead sponsor
Imam Abdulrahman Bin Faisal University
Sponsor institution
This trial is not recruiting at the moment. You can still explore other options: